Concepedia

Jonathan A. Leff

JA

30

Publications

2.5K

Citations

25

H-Index

1991

Active since

Affiliations

University of Colorado Health(Current)

University of Colorado Denver

Ascendis Pharma (Denmark)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Amgen (United States)

Jonathan A. Leff is an author at University of Colorado Health specializing in medicine, pharmacology, and oxidative stress.

Top concepts

Publications per year

1991–2020

30

Publications

30

Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced Bronchoconstriction

Jonathan A. Leff, David S. Pearlman, Edwin A. Bronsky et al. · New England Journal of Medicine · 1998 · 555 citations · Full text

6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis

Roland M. du Bois, Carlo Albera, Williamson Z. Bradford et al. · European Respiratory Journal · 2013 · 236 citations · Full text

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction

César Villarán, Shane O’Neill, Arthur Helbling et al. · Journal of Allergy and Clinical Immunology · 1999 · 181 citations · Full text

, , +5

All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials

Talmadge E. King, Carlo Albera, Williamson Z. Bradford et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 155 citations · Full text

Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

Haiyung Cheng, Jonathan A. Leff, Raju D. Amin et al. · Pharmaceutical Research · 1996 · 139 citations

Rows per page

1–5 of 30